Editorial
Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia
Abstract
Within the hematopoietic system, core binding factor beta (CBFβ) normally forms a complex with the master hematopoietic regulator, RUNX1 (1) and stabilizes its binding to DNA (2).
